IP Library Assignment 033987/0440
Patent Assignment
Reel/Frame 033987/0440

Release of Security Interest

Recorded: 2014-10-14 Pages: 5
Assignor
JPMORGAN CHASE BANK, N.A.
Executed: 2014-10-14
Assignee
SOLSTICE NEUROSCIENCES, LLC
4010 DUPONT CIRCLE, SUITE L-07, LOUISVILLE, KENTUCKY, 40207
Covered Properties (6)
Method for Treating Tardive Dyskinesia with Botulinum Toxin Type B
Patent: 6,645,496 →
Application: 09/796,068 →
Publication: US 2001/0018415
Method for Treating Neuromuscular Disorders and Conditions with Botulinum Toxin Types a and B
Patent: 6,872,397 →
Application: 09/812,113 →
Publication: US 2001/0012833
Method for Treating Essential Tremor with Botulinum Toxin Type B
Patent: 6,861,058 →
Application: 09/883,122 →
Publication: US 2001/0041181
Method for Treating Cervical Dystonia with Botulinum Toxin Type B
Patent: 6,632,433 →
Application: 09/884,830 →
Publication: US 2001/0043930
Method and Compositions for the Treatment of Cerebral Palsy
Patent: 6,448,231 →
Application: 09/900,380 →
Publication: US 2001/0046962
Method for Treating Muscle Spasm with Botulinum Toxin Type B
Patent: 6,841,156 →
Application: 09/904,057 →
Publication: US 2001/0053364
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement Mar 6, 2007
From: SOLSTICE NEUROSCIENCES, INC.
To: NEXBANK, SSB
Reel/Frame 018969/0513 →
Release and Reassignment Aug 10, 2010
From: NEXBANK, SSB
To: SOLSTICE NEUROSCIENCES, INC.
Reel/Frame 024812/0653 →
Merger Sep 6, 2012
From: SOLSTICE NEUROSCIENCES, INC.
To: SOLSTICE NEUROSCIENCES, LLC
Reel/Frame 028917/0475 →
Security Agreement Sep 26, 2012
From: SOLSTICE NEUROSCIENCES, LLC
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 029041/0720 →